DK1151121T3 - Vektorer og virale vacciner baseret på rekombinante porcine adenovirus - Google Patents

Vektorer og virale vacciner baseret på rekombinante porcine adenovirus

Info

Publication number
DK1151121T3
DK1151121T3 DK00903750T DK00903750T DK1151121T3 DK 1151121 T3 DK1151121 T3 DK 1151121T3 DK 00903750 T DK00903750 T DK 00903750T DK 00903750 T DK00903750 T DK 00903750T DK 1151121 T3 DK1151121 T3 DK 1151121T3
Authority
DK
Denmark
Prior art keywords
adenovirus
porcine adenovirus
porcine
vivo
nucleotide sequence
Prior art date
Application number
DK00903750T
Other languages
Danish (da)
English (en)
Inventor
Marc Eloit
Bernard Georges Klonjkowski
Original Assignee
Merial Sas
Envt Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas, Envt Toulouse filed Critical Merial Sas
Application granted granted Critical
Publication of DK1151121T3 publication Critical patent/DK1151121T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00903750T 1999-02-11 2000-02-08 Vektorer og virale vacciner baseret på rekombinante porcine adenovirus DK1151121T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901813A FR2789695B1 (fr) 1999-02-11 1999-02-11 Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs

Publications (1)

Publication Number Publication Date
DK1151121T3 true DK1151121T3 (da) 2006-05-29

Family

ID=9542037

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00903750T DK1151121T3 (da) 1999-02-11 2000-02-08 Vektorer og virale vacciner baseret på rekombinante porcine adenovirus

Country Status (16)

Country Link
US (1) US7109025B1 (zh)
EP (1) EP1151121B1 (zh)
JP (1) JP2002537766A (zh)
KR (1) KR100818673B1 (zh)
CN (2) CN1262664C (zh)
AT (1) ATE316580T1 (zh)
AU (1) AU781195B2 (zh)
BR (1) BR0008205A (zh)
CA (1) CA2362454C (zh)
DE (1) DE60025701T2 (zh)
DK (1) DK1151121T3 (zh)
ES (1) ES2258970T3 (zh)
FR (1) FR2789695B1 (zh)
MX (1) MXPA01008069A (zh)
PL (1) PL205524B1 (zh)
WO (1) WO2000047756A1 (zh)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
EP1157121B1 (en) * 1999-03-08 2013-04-24 Boehringer Ingelheim Vetmedica GmbH Prrsv replicon
DK2251419T3 (da) * 1999-04-22 2012-07-02 Us Agriculture Porcint reproduktions- og respirations-syndrom-vaccine baseret på isolat JA-142
WO2001083737A2 (en) * 2000-05-03 2001-11-08 University Of Guelph Porcine adenovirus type 5 vector and vaccine
CN1840656B (zh) 2001-03-27 2010-06-02 萨斯喀彻温大学 培养环状病毒的方法
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
BRPI0510928A (pt) 2004-06-18 2007-11-13 Univ Minnesota identificação de organismos viralmente infectados e vacinados
US7632636B2 (en) * 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
MX2007015849A (es) 2005-06-24 2008-02-22 Univ Minnesota Virus del sindrome respiratorio y reproductivo porcino, clones infecciosos, mutantes de los mismos, y metodos de uso.
MX356667B (es) * 2005-12-29 2018-06-08 Boehringer Ingelheim Vetmedica Inc Uso de una composicion inmunogenica de pcv2 para reducir los sintomas clinicos en cerdos.
US20080226669A1 (en) 2005-12-29 2008-09-18 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
EP2101815A4 (en) 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS
JP5200223B2 (ja) * 2006-12-15 2013-06-05 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド Ｐｃｖ２抗原によるブタの処置
EP1941903A1 (en) * 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
KR20100103535A (ko) * 2007-12-31 2010-09-27 베링거잉겔하임베트메디카인코퍼레이티드 외래 아미노산 삽입물을 갖는 ｐｃｖ２ ｏｒｆ２ 바이러스 유사 입자
MX2010007815A (es) * 2008-01-23 2010-08-10 Boehringer Ingelheim Vetmed Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
BRPI0917887A2 (pt) * 2008-08-25 2019-09-03 Boehringer Ingelheim Vetmedica Inc vacina contra síndrome reprodutiva e respiratória suína altamente patogênica (hp pprs)
AU2009100018B4 (en) * 2008-10-15 2009-09-03 Australasian Pork Research Institute Ltd A Method of vaccination
US20100150959A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. PCV 2-Based Methods and Compositions for the Treatment of Pigs
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
DK2959916T3 (en) 2011-02-17 2018-10-29 Boehringer Ingelheim Vetmedica Gmbh New European PRRSV strain.
CA2827337C (en) 2011-02-17 2019-07-09 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
EP2737059A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH Novel prrs virus inducing type i interferon in susceptible cells
CN102766604B (zh) * 2012-06-19 2013-06-05 河南农业大学 一种猪流感病毒毒株及其应用
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
US9649370B2 (en) 2013-05-08 2017-05-16 Protatek International, Inc. Vaccine for PCV2 and mycoplasma
MX2016003855A (es) 2013-09-25 2016-08-04 Zoetis Services Llc Composicion de vacuna de circovirus porcino tipo 2b divergente y procedimientos de uso.
MX2016004063A (es) 2013-10-02 2016-06-06 Boehringer Ingelheim Vetmed Variante de la proteina pcv2 orf2 y particulas similares al virus compuestas por esta.
CN105273067A (zh) * 2015-03-13 2016-01-27 中国疾病预防控制中心病毒病预防控制所 一种编码MERS-CoV棘突蛋白的重组41型腺病毒载体疫苗
EP3294876A1 (en) 2015-05-14 2018-03-21 Merial, Inc. Method for porcine circovirus production and pcv2 vaccines
CN105368796A (zh) * 2015-09-09 2016-03-02 河南农业大学 一种表达ppv vp2基因和猪il-18基因的重组猪伪狂犬病毒株
UA127859C2 (uk) * 2016-11-03 2024-01-31 Бьорінгер Інгельхайм Ветмедіка Гмбх Вакцина проти свинячого парвовірусу
CN109206491A (zh) * 2017-07-07 2019-01-15 浙江海隆生物科技有限公司 猪伪狂犬病毒gD蛋白的制备方法及猪伪狂犬病毒亚单位疫苗和应用
CN110038124B (zh) * 2019-05-13 2023-04-14 天康生物股份有限公司 猪瘟-猪传染性胸膜肺炎二联亚单位的疫苗及其制备方法和应用
CN112834744A (zh) * 2020-12-31 2021-05-25 天津瑞普生物技术股份有限公司 一种猪群体内腺病毒3型中和抗体阳性率的elisa试剂盒及其检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1154718A (zh) * 1994-07-29 1997-07-16 美国氰胺公司 与主要组织相容性复合体i类重链表达负调节有关的人巨细胞病毒基因区域的鉴定
ES2105984B1 (es) * 1995-11-30 1998-04-16 Iberica Cyanamid Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
AUPO856097A0 (en) * 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6492343B1 (en) * 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome

Also Published As

Publication number Publication date
DE60025701T2 (de) 2006-10-19
FR2789695B1 (fr) 2003-03-07
EP1151121A1 (fr) 2001-11-07
CA2362454A1 (en) 2000-08-17
KR20020013502A (ko) 2002-02-20
US7109025B1 (en) 2006-09-19
CN1343257A (zh) 2002-04-03
EP1151121B1 (fr) 2006-01-25
AU781195B2 (en) 2005-05-12
DE60025701D1 (de) 2006-04-13
FR2789695A1 (fr) 2000-08-18
BR0008205A (pt) 2002-04-02
PL205524B1 (pl) 2010-04-30
CN1869243A (zh) 2006-11-29
KR100818673B1 (ko) 2008-04-01
CN1869243B (zh) 2016-01-20
PL350182A1 (en) 2002-11-18
WO2000047756A1 (fr) 2000-08-17
ES2258970T3 (es) 2006-09-16
MXPA01008069A (es) 2003-09-10
CA2362454C (en) 2011-12-20
CN1262664C (zh) 2006-07-05
AU2553700A (en) 2000-08-29
JP2002537766A (ja) 2002-11-12
ATE316580T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
DK1151121T3 (da) Vektorer og virale vacciner baseret på rekombinante porcine adenovirus
DE69534746D1 (de) Aav-capsidvehikel für den molekularen transport
DE69535359D1 (de) Rekombinantes herpesvirus aus trufhähnen und seine verwendungen
WO1995016048A3 (en) Recombinant protein production in bovine adenovirus expression vector system
HUP9802217A2 (hu) Rekombináns MVA-vírus és alkalmazása
CA2305623A1 (fr) Circovirus porcins, vaccins et reactifs de diagnostic
HUP0101207A2 (hu) Rekombináns és adjuvánstartalmú élő oltóanyagok
PT1098961E (pt) Vírus atenuados produzidos por engenharia genética indutores de interferão
WO2000003030A3 (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
GB0014986D0 (en) Polypeptide
NZ503039A (en) Recombinant porcine adenovirus vector
WO2001083737A3 (en) Porcine adenovirus type 5 vector and vaccine
IL168374A (en) Vaccines against west nile virus
DE69929530D1 (de) Attenuierte pferdeherpesvirus
IL146191A0 (en) Viral expression vectors
NO20005482D0 (no) Rekombinant virus som uttrykker fremmed DNA som koder for Felin CD80, Felin CTLA-4 eller Felin CD86 og anvendelse derav
ATE431421T1 (de) In der e1b-region deletierte, adenovirale shuttle-vektoren
Both et al. Towards a vaccine against bovine rotaviruses.
PT99540A (pt) Processo para obtencao de virus de herpes recombinantes genes vectores e plasmidios utilizados nesse processo e processo para a preparacao de vacinas a base dos mencionados virus recombinantes
MY157873A (en) Recombinant mva virus, and the use thereof
MX9709514A (es) Viruses de fowlpox recombinantes y usos de los mismos.
TH43073B (th) เวกเตอร์ไวรัสและวัคซีนไวรัสที่ใช้อะดีโนไวรัสของสุกรชนิดรีคอมบิแนนท์และถอดแบบได้
TH1348EX (th) การประดิษฐ์ไวรัสที่มีโปรตีนพื้นผิวเป็นรีคอมบิแนนท์โปรตีน
WO2004108940A3 (en) Viral genome vectors
TH58477B (th) จีนแคลิซิไวรัสของสัตว์จำพวกแมว และวัคซีนโดยเฉพาะวัคซีนรีคอมบิแนนท์